NCT07218666
- Conditions
- Aggressive Variant Prostate Carcinoma
- Locations
-
- Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States
Clinical trial condition
Aggressive Variant Prostate Carcinoma
Explore clinical trials studying Aggressive Variant Prostate Carcinoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Aggressive Variant Prostate Carcinoma trial results
Active, Not Recruiting
Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer
NCT04592237
- Conditions
- Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Genital Diseases, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers
NCT04388852
- Conditions
- Adenocarcinoma, Aggressive Variant Prostate Carcinoma, Carcinoma, +34 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States